| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $386.0M | — | -4.7% |
| Cost of Revenue | $281.0M | — | -4.4% |
| Gross Profit | $105.0M | — | -5.4% |
| R&D Expense | $13.0M | — | +0.0% |
| SG&A Expense | $86.0M | — | +10.3% |
| Operating Income | -$6.0M | — | +96.6% |
| Pre-tax Income | -$15.0M | — | +92.8% |
| Income Tax | -$1.0M | — | +97.7% |
| Net Income | -$12.0M | — | +92.7% |
| EPS (Basic) | -$0.26 | — | +92.6% |
| EPS (Diluted) | -$0.26 | — | +92.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $304.0M | +41.4% | +38.8% |
| Accounts Receivable | $190.0M | -21.5% | +16.6% |
| Inventory | $565.0M | -0.5% | +7.0% |
| Current Assets | $1.15B | -4.2% | +8.0% |
| Total Assets | $4.52B | -2.0% | -13.6% |
| Current Liabilities | $366.0M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $14.0M | — | -39.1% |
| Investing Cash Flow | $2.0M | — | +111.1% |
| Financing Cash Flow | -$21.0M | — | +4.5% |
| -13.9% |
| Long-term Debt | $1.39B | +0.2% | +5.6% |
| Stockholders' Equity | $1.88B | -1.4% | -27.5% |